ALLO Operating Cash Flow (Statement)
Allogene Therapeutics Inc · Operating Cash Flow (Statement)
ALLO Operating Cash Flow (Statement)
Latest reported-$102.20Mperiod ending
ALLO TTM Cash from Operations (-$44.65M → -$102.20M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ALLO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -102,196,000 | |
| -109,230,000 | |
| -149,246,000 | |
| -158,345,000 | |
| -172,772,000 | |
| -197,330,000 | |
| -200,300,000 | |
| -217,309,000 | |
| -228,724,000 | |
| -226,993,000 | |
| -237,733,000 | |
| -246,122,000 | |
| -238,247,000 | |
| -218,921,000 | |
| -220,519,000 | |
| -203,859,000 | |
| -205,082,000 | |
| -203,721,000 | |
| -184,812,000 | |
| -149,351,000 | |
| -138,061,000 | |
| -123,612,000 | |
| -115,093,000 | |
| -155,385,000 | |
| -149,732,000 | |
| -147,903,000 | |
| -137,350,000 | |
| -108,564,000 | |
| -93,759,000 | |
| -74,914,000 | |
| -44,653,000 | |
| -23,172,000 |